U.S. markets close in 2 hours 40 minutes

Insulet Corporation (PODD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
165.46-3.37 (-2.00%)
As of 01:19PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close168.83
Bid165.86 x 900
Ask165.98 x 1100
Day's Range163.35 - 169.45
52 Week Range125.82 - 335.91
Avg. Volume875,227
Market Cap11.57B
Beta (5Y Monthly)1.04
PE Ratio (TTM)56.28
EPS (TTM)2.94
Earnings DateMay 02, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est238.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
32% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PODD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Insulet Corporation
    Analyst Report: Insulet CorporationInsulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
    Fair Value
    Economic Moat
    19 hours agoMorningstar
View more